Skip to content
OpenCapital
Get started

Inspire Medical Systems INSP Change in receivables

Change in receivables at other companies

Medtronic logo
MedtronicMDT
$287M+15.3%

Other financials

Income statement

See full
Revenue$204.6M+1.6%
Gross profit$176.9M+3.7%
Operating income-$1.1M+24.7%
Net income-$11.3M-477%
EPS (diluted)-$0.39-490%

Balance sheet

See full
Cash & equivalents$98.9M+83.6%
Total debt$29.6M-11.8%
Total equity$792.3M+24.6%
Total assets$911.4M+24.7%

Cash flow

See full
Operating cash flow$12.8M+292%
CapEx$9.7M+15.7%
Free cash flow$3.1M+121%

Valuation

See full
Market cap$1.24B-67.8%
Enterprise value$1.18B-69.4%
P/E9.5×-48.6×
P/S1.4×-3.2×

Profitability

See full
Gross margin85.8%+1.1pp
Operating margin5.6%-0.3pp
Net margin14.3%+6.4pp
FCF margin10.6%+1.2pp

Returns & leverage

See full
Return on equity18.4%+7.5pp
Debt / equity0×0.0×
Current ratio6.3×-2.7×

Where this comes from

Reported directly by Inspire Medical Systems in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInReceivables.

The official record: Inspire Medical Systems’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about Inspire Medical Systems's change in receivables.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Inspire Medical Systems's change in receivables?
Inspire Medical Systems (INSP) reported change in receivables of -$14.29M in Q1 2026.
How has Inspire Medical Systems's change in receivables changed year-over-year?
Inspire Medical Systems's change in receivables decreased by 5331.6% year-over-year, from -$263K to -$14.29M.
What is the long-term trend for Inspire Medical Systems's change in receivables?
Over 2 years (2021 to 2023), Inspire Medical Systems's change in receivables has grown at a 80.8% compound annual growth rate (CAGR), from $9.24M to $30.22M.
What does change in receivables mean?
Change in total receivables including trade and non-trade receivables.